CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document-intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (www.consort-statement.org) should be helpful resources to improve reporting of randomised trials.

[1]  Guosheng Yin,et al.  Fundamentals of Clinical Trials , 2012 .

[2]  G. Antes,et al.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials , 2011 .

[3]  M. Pittler Systematic Reviews in Health Care: Meta‐analysis in Context , 2010 .

[4]  Sally Hopewell,et al.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.

[5]  M. Outzen Splint for Base-of-Thumb Osteoarthritis: A Randomized Trial , 2010 .

[6]  World Medical Association (WMA) Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.

[7]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[8]  A. Astrup,et al.  Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study , 2009, The Lancet.

[9]  Isabelle Boutron,et al.  Reporting of safety results in published reports of randomized controlled trials. , 2009, Archives of internal medicine.

[10]  B. Koes,et al.  Supervised exercise therapy versus usual care for patellofemoral pain syndrome: an open label randomised controlled trial , 2009, BMJ : British Medical Journal.

[11]  E. Antman,et al.  Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial , 2009, The Lancet.

[12]  Amir Herman,et al.  Intention-to-treat analysis and accounting for missing data in orthopaedic randomized clinical trials. , 2009, Journal of Bone and Joint Surgery. American volume.

[13]  E. Verhagen,et al.  Effect of unsupervised home based proprioceptive training on recurrences of ankle sprain: randomised controlled trial , 2009, BMJ : British Medical Journal.

[14]  J. Hofland,et al.  Intravenous fluid restriction after major abdominal surgery: a randomized blinded clinical trial , 2009, Trials.

[15]  Donald A Williamson,et al.  Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. , 2009, The New England journal of medicine.

[16]  Satish Iyengar,et al.  Prevention of depression in at-risk adolescents: a randomized controlled trial. , 2009, JAMA.

[17]  M. Manary,et al.  Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial , 2009, BMJ : British Medical Journal.

[18]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[19]  Douglas G Altman,et al.  Missing outcomes in randomized trials: addressing the dilemma , 2009, Open medicine : a peer-reviewed, independent, open-access journal.

[20]  Philippe Ravaud,et al.  Reporting of sample size calculation in randomised controlled trials: review , 2009, BMJ : British Medical Journal.

[21]  R. Findling,et al.  Controlled Clinical Trial of Zolpidem for the Treatment of Insomnia Associated With Attention-Deficit/ Hyperactivity Disorder in Children 6 to 17 Years of Age , 2009, Pediatrics.

[22]  B. Muthén,et al.  Adaptive designs for randomized trials in public health. , 2009, Annual review of public health.

[23]  W. Elliott Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2009 .

[24]  C. Ramsay,et al.  Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial , 2008, BMJ : British Medical Journal.

[25]  Douglas G Altman,et al.  Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols , 2008, BMJ : British Medical Journal.

[26]  D. Moher,et al.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement , 2008, BMJ : British Medical Journal.

[27]  Brian Hutton,et al.  Does analysis using “last observation carried forward” introduce bias in dementia research? , 2008, Canadian Medical Association Journal.

[28]  R. Ferrari,et al.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[29]  J. Ioannidis,et al.  Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.

[30]  Saravu R Narahari,et al.  Evidence-based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model. , 2008, Journal of alternative and complementary medicine.

[31]  S. Evans,et al.  Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet , 2008, The Lancet.

[32]  Jesper Nielsen,et al.  Laypersons' understanding of relative risk reductions: Randomised cross-sectional study , 2008, BMC Medical Informatics Decis. Mak..

[33]  Joan Webster,et al.  Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial , 2008, BMJ : British Medical Journal.

[34]  Nilay D Shah,et al.  Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. , 2008, Mayo Clinic proceedings.

[35]  Carl Heneghan,et al.  What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.

[36]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[37]  J. Manson,et al.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.

[38]  K. Papp,et al.  Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study , 2008, The Lancet.

[39]  D. Moher,et al.  Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors' , 2008, Trials.

[40]  Harlan M Krumholz,et al.  Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. , 2008, JAMA.

[41]  P. Lane Handling drop‐out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches , 2008, Pharmaceutical statistics.

[42]  F. McAlister Applying the Results of Systematic Reviews at the Bedside , 2008 .

[43]  Douglas G Altman,et al.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.

[44]  Sergio Sismondo,et al.  Pharmaceutical company funding and its consequences: a qualitative systematic review. , 2008, Contemporary clinical trials.

[45]  L. Katz,et al.  Uterine Exteriorization Compared With In Situ Repair at Cesarean Delivery: A Randomized Controlled Trial , 2008, Obstetrics and gynecology.

[46]  Sangeeta Mehta,et al.  Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.

[47]  D. Moher,et al.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. , 2008, Annals of internal medicine.

[48]  K. Barnhart,et al.  Multicenter Comparison of the Contraceptive Ring and Patch: A Randomized Controlled Trial , 2008, Obstetrics and gynecology.

[49]  B. Psaty,et al.  Generalizability of the results of randomized trials. , 2008, Archives of internal medicine.

[50]  D. Streiner Missing data and the trouble with LOCF , 2008, Evidence-based mental health.

[51]  D. Moher,et al.  CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration , 2008, PLoS medicine.

[52]  Gordon H Guyatt,et al.  In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter? , 2008, PLoS medicine.

[53]  T. Wachs,et al.  CONSORT for reporting randomised trials in journal and conference abstracts , 2008 .

[54]  A D Oxman,et al.  Randomisation to protect against selection bias in healthcare trials. , 2011, The Cochrane database of systematic reviews.

[55]  Mike Clarke,et al.  Standardising outcomes for clinical trials and systematic reviews , 2007, Trials.

[56]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[57]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[58]  R. Holubkov,et al.  Carvedilol for children and adolescents with heart failure: a randomized controlled trial. , 2007, JAMA.

[59]  Ezekiel Uba Nwose,et al.  The Lancet Handbook of Essential Concepts in Clinical Research , 2007 .

[60]  S. Shapiro,et al.  The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say? , 2007, Clinical trials.

[61]  J. Hilden,et al.  Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. , 2007, International journal of epidemiology.

[62]  O. Dalesio,et al.  Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review , 2007, The Lancet.

[63]  Lisa Bero,et al.  Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others , 2007, PLoS medicine.

[64]  Nicholas C. Ide,et al.  Issues in the registration of clinical trials. , 2007, JAMA.

[65]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[66]  M. Clarke,et al.  Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report , 2007, Journal of the Royal Society of Medicine.

[67]  John P A Ioannidis,et al.  Limitations are not properly acknowledged in the scientific literature. , 2007, Journal of clinical epidemiology.

[68]  R. Anderson,et al.  Impact and Process Evaluation of Integrated Community and Clinic-Based HIV-1 Control: A Cluster-Randomised Trial in Eastern Zimbabwe , 2007, PLoS medicine.

[69]  G. Leung,et al.  Quality of Reporting of Key Methodological Items of Randomized Controlled Trials in Clinical Ophthalmic Journals , 2007, Ophthalmic epidemiology.

[70]  P Middleton,et al.  Technical editing of research reports in biomedical journals. , 2007, The Cochrane database of systematic reviews.

[71]  A. Michalsen,et al.  Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity , 2006, BMC medical research methodology.

[72]  Paul Gallo,et al.  PhRMA Working Group on Adaptive Designs: Introduction to the Full White Paper , 2006 .

[73]  R. Temple,et al.  FDA perspective on trials with interim efficacy evaluations , 2006, Statistics in medicine.

[74]  D. Moher,et al.  Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review , 2006, The Medical journal of Australia.

[75]  A. Colevas,et al.  Adverse event reporting in publications compared with sponsor database for cancer clinical trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  A Oakley,et al.  Assessment of generalisability in trials of health interventions: suggested framework and systematic review , 2006, BMJ : British Medical Journal.

[77]  R. Buchbinder,et al.  Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial , 2006, BMC musculoskeletal disorders.

[78]  T. Mills,et al.  Measuring Health: A Guide to Rating Scales and Questionnaires , 2006 .

[79]  Asbjørn Hróbjartsson,et al.  Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors , 2006, Clinical trials.

[80]  Peter C Gøtzsche,et al.  Believability of relative risks and odds ratios in abstracts: cross sectional study , 2006, BMJ : British Medical Journal.

[81]  I. Chalmers From optimism to disillusion about commitment to transparency in the medico-industrial complex. , 2006, Journal of the Royal Society of Medicine.

[82]  Holger J Schünemann,et al.  Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials , 2006, Clinical orthopaedics and related research.

[83]  V. Barbour,et al.  The impact of open access upon public health. , 2006, Bulletin of the World Health Organization.

[84]  P. Rothwell,et al.  Factors That Can Affect the External Validity of Randomised Controlled Trials , 2006, PLoS clinical trials.

[85]  David Moher,et al.  Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement , 2006, Annals of Internal Medicine.

[86]  Douglas G Altman,et al.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. , 2006, JAMA.

[87]  R. Greenblatt,et al.  Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols , 2005, AIDS.

[88]  Gordon H Guyatt,et al.  Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.

[89]  Emmanuel Lagarde,et al.  Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial , 2005, PLoS medicine.

[90]  M Egger,et al.  The causes and effects of socio-demographic exclusions from clinical trials. , 2005, Health technology assessment.

[91]  P. Bower,et al.  Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials. , 2005, Health technology assessment.

[92]  R. Horton,et al.  Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. , 2005, The Medical journal of Australia.

[93]  Patrick J. Kelly,et al.  A Practical Comparison of Group-Sequential and Adaptive Designs , 2005, Journal of biopharmaceutical statistics.

[94]  Brian Hutton,et al.  Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? , 2005, Clinical trials.

[95]  C. Gamble,et al.  Identification and impact of outcome selection bias in meta‐analysis , 2005, Statistics in medicine.

[96]  R. Horton,et al.  Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors , 2005, The Lancet.

[97]  K. Schulz,et al.  Sample size calculations in randomised trials: mandatory and mystical , 2005, The Lancet.

[98]  A. Hrõbjartsson,et al.  Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study , 2005, BMJ : British Medical Journal.

[99]  Douglas G Altman,et al.  Epidemiology and reporting of randomised trials published in PubMed journals , 2005, The Lancet.

[100]  D. Spiegelhalter,et al.  Issues in data monitoring and interim analysis of trials. , 2005, Health technology assessment.

[101]  P. Rothwell,et al.  External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.

[102]  B. Phillips Randomisation. , 1991, Archives of disease in childhood.

[103]  J. Stoner Cross-over Trials in Clinical Research , 2004 .

[104]  G. Norman,et al.  Randomized controlled trials. , 2004, AJR. American journal of roentgenology.

[105]  J. Ioannidis,et al.  Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.

[106]  D. Altman,et al.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research , 2004, Canadian Medical Association Journal.

[107]  Ian R White,et al.  Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals , 2004, Clinical trials.

[108]  Leah G Ward,et al.  Accuracy of Abstracts for Original Research Articles in Pharmacy Journals , 2004, The Annals of pharmacotherapy.

[109]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[110]  D. Sackett Turning a blind eye:Why we don't test for blindness at the end of our trials , 2004, BMJ : British Medical Journal.

[111]  Peter Fonagy,et al.  Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data , 2004, The Lancet.

[112]  D. Altman,et al.  CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.

[113]  C. Meinert,et al.  Treatment effects monitoring committees and early stopping in large clinical trials , 2004, Clinical trials.

[114]  D. Spiegelhalter,et al.  Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study , 2004, Clinical trials.

[115]  Duff Waring,et al.  Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials , 2004, BMJ : British Medical Journal.

[116]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[117]  D. Juurlink,et al.  The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903] , 2003, BMC clinical pharmacology.

[118]  G. Piaggio,et al.  The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial , 2003, BMC medical research methodology.

[119]  F. Song,et al.  Evaluating non-randomised intervention studies. , 2003, Health technology assessment.

[120]  Christian Gluud,et al.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? , 2003, JAMA.

[121]  C A Gatsonis,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2003, Clinical radiology.

[122]  B. Beermann,et al.  Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications , 2003, BMJ : British Medical Journal.

[123]  B. Djulbegovic,et al.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.

[124]  J. Ware,et al.  Interpreting incomplete data in studies of diet and weight loss. , 2003, The New England journal of medicine.

[125]  Douglas G Altman,et al.  Analysis and reporting of factorial trials: a systematic review. , 2003, JAMA.

[126]  D. Rennie,et al.  Stopping medical research to save money: a broken pact with researchers and patients. , 2003, JAMA.

[127]  D. Tate,et al.  Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. , 2003, JAMA.

[128]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[129]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[130]  I. Leviton,et al.  Registering clinical trials. , 2003, Journal of the American Medical Association (JAMA).

[131]  A. Tonks,et al.  A clinical trials register for Europe , 2002, BMJ : British Medical Journal.

[132]  R. Kruse,et al.  Intention-to-treat analysis: who is in? Who is out? , 2002, The Journal of family practice.

[133]  L. Kjaergard,et al.  Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ , 2002, BMJ : British Medical Journal.

[134]  G. Guyatt,et al.  In the dark: the reporting of blinding status in randomized controlled trials. , 2002, Journal of clinical epidemiology.

[135]  J. Karlawish,et al.  The continuing unethical conduct of underpowered clinical trials. , 2002, JAMA.

[136]  Steve McDonald,et al.  Development of the Cochrane Collaboration’s Central Register of Controlled Clinical Trials , 2002, Evaluation & the health professions.

[137]  Alex H S Harris,et al.  The Accuracy of Abstracts in Psychology Journals , 2002, The Journal of psychology.

[138]  I. Chalmers,et al.  The Landscape and Lexicon of Blinding in Randomized Trials , 2002, Annals of Internal Medicine.

[139]  David L Streiner,et al.  The Case of the Missing Data: Methods of Dealing with Dropouts and other Research Vagaries , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[140]  D. Altman,et al.  Reporting on Statistical Methods To Adjust for Confounding: A Cross-Sectional Survey , 2002, Annals of Internal Medicine.

[141]  D Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[142]  Douglas G Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[143]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[144]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[145]  D. Rennie CONSORT revised--improving the reporting of randomized trials. , 2001, JAMA.

[146]  G. Guyatt,et al.  Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. , 2001, JAMA.

[147]  M Egger,et al.  Value of flow diagrams in reports of randomized controlled trials. , 2001, JAMA.

[148]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[149]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[150]  R. Collins,et al.  Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials , 2001, The Lancet.

[151]  J. Ioannidis,et al.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. , 2001, JAMA.

[152]  J L Hutton,et al.  Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. , 2000, Statistics in medicine.

[153]  Pincus Mm Intention-to-treat analysis and the goals of clinical trials. , 2000 .

[154]  A. Catanzaro,et al.  Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis , 2000, Annals of Internal Medicine.

[155]  J. Deeks,et al.  Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial , 2000, BMJ : British Medical Journal.

[156]  A. LaCroix,et al.  Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults , 2000, Annals of Internal Medicine.

[157]  C. Weijer,et al.  Reporting the study populations of clinical trials. Clear transmission or static on the line? , 2000, Journal of clinical epidemiology.

[158]  Phil Barton,et al.  Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial , 2000, The Lancet.

[159]  Alan Cantor,et al.  The uncertainty principle and industry-sponsored research , 2000, The Lancet.

[160]  Å. Westin,et al.  Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety , 2000, BMJ : British Medical Journal.

[161]  F. Davidoff News from the International Committee of Medical Journal Editors , 2000, Annals of Internal Medicine.

[162]  N. Nagelkerke,et al.  Estimating treatment effects in randomized clinical trials in the presence of non-compliance. , 2000, Statistics in medicine.

[163]  Giuseppe Mancia,et al.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.

[164]  P. Mease,et al.  Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial , 2000, The Lancet.

[165]  L. Sadler,et al.  A randomised controlled trial and meta‐analysis of active management of labour , 2000, BJOG : an international journal of obstetrics and gynaecology.

[166]  S. Carley,et al.  An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb , 2000, BMJ : British Medical Journal.

[167]  B. Morrey,et al.  Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement , 2000, Annals of Internal Medicine.

[168]  J M Lachin,et al.  Statistical considerations in the intent-to-treat principle. , 2000, Controlled clinical trials.

[169]  K. Lee,et al.  Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? , 2000, American heart journal.

[170]  M. Martínez-González,et al.  Intention to treat analysis is related to methodological quality , 2000, BMJ : British Medical Journal.

[171]  M. Staun,et al.  Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. , 2000, Gastroenterology.

[172]  S. Assmann,et al.  Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.

[173]  T. Lang Masking or blinding? An unscientific survey of mostly medical journal editors on the great debate. , 2000, MedGenMed : Medscape general medicine.

[174]  C. Adams,et al.  Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia , 2000, British Journal of Psychiatry.

[175]  H. Williams,et al.  How well are randomized controlled trials reported in the dermatology literature? , 2000, Archives of dermatology.

[176]  S Greenland,et al.  Principles of multilevel modelling. , 2000, International journal of epidemiology.

[177]  G D Murray,et al.  Promoting good research practice , 2000, Statistical methods in medical research.

[178]  D. Ashby,et al.  Randomized controlled trials in cystic fibrosis (1966–1997) categorized by time, design, and intervention , 2000, Pediatric pulmonology.

[179]  A J Sutton,et al.  Publication and related biases. , 2000, Health technology assessment.

[180]  S. Golder,et al.  The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. , 2000, Health technology assessment.

[181]  J. Bodfish,et al.  Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. , 1999, The New England journal of medicine.

[182]  D G Altman,et al.  Calculating the number needed to treat for trials where the outcome is time to an event , 1999, BMJ.

[183]  D. DeMets,et al.  The agonising negative trend in monitoring of clinical trials , 1999, The Lancet.

[184]  C. Gluud,et al.  Randomized clinical trials in Hepatology: Predictors of quality , 1999, Hepatology.

[185]  S. Hollis,et al.  What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.

[186]  Douglas G Altman,et al.  How to randomise , 1999, BMJ.

[187]  C Cates,et al.  Confidence intervals for the number needed to treat , 1999 .

[188]  S. Goodman Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy , 1999, Annals of Internal Medicine.

[189]  K. Khan,et al.  Logistic regression models in obstetrics and gynecology literature. , 1999, Obstetrics and gynecology.

[190]  M Docherty,et al.  The case for structuring the discussion of scientific papers , 1999, BMJ.

[191]  R M Pitkin,et al.  Accuracy of data in abstracts of published research articles. , 1999, JAMA.

[192]  S. Pocock,et al.  Trials stopped early: too good to be true? , 1999, The Lancet.

[193]  F. Baughman Treatment of attention-deficit/hyperactivity disorder. , 1999, JAMA.

[194]  D. Elbourne,et al.  A randomised controlled trial of care of the perineum during second stage of normal labour , 1998, British journal of obstetrics and gynaecology.

[195]  C. Adams,et al.  Content and quality of 2000 controlled trials in schizophrenia over 50 years , 1998, BMJ.

[196]  J. Donovan,et al.  Reporting on quality of life in randomised controlled trials: bibliographic study , 1998, BMJ.

[197]  P. Bath,et al.  Quality of full and final publications reporting acute stroke trials: a systematic review. , 1998, Stroke.

[198]  T. Kaptchuk,et al.  Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine , 1998, Bulletin of the history of medicine.

[199]  T. Treasure,et al.  Minimisation: the platinum standard for trials? , 1998, BMJ.

[200]  D. Ashby,et al.  Time to publication as full reports of abstracts of randomized controlled trials in cystic fibrosis , 1998, Pediatric pulmonology.

[201]  F. Davidoff,et al.  Changes to manuscripts during the editorial process: characterizing the evolution of a clinical paper. , 1998, JAMA.

[202]  C. Junker Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German. , 1998, JAMA.

[203]  Michael Clarke,et al.  Non-random Reflections on Health Services Research , 1998, BMJ.

[204]  C. Meinert Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.

[205]  D Moher,et al.  CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.

[206]  C. Meinert Masked monitoring in clinical trials--blind stupidity? , 1998, New England Journal of Medicine.

[207]  S. Bolton Independence and Statistical Inference in Clinical Trial Designs: A Tutorial Review , 1998, Journal of clinical pharmacology.

[208]  K. Ah-See,et al.  A qualitative assessment of randomized controlled trials in otolaryngology , 1998, The Journal of Laryngology & Otology.

[209]  G H Guyatt,et al.  Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. , 1998, JAMA.

[210]  C Weijer,et al.  A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group. , 1998, Journal of clinical epidemiology.

[211]  T. Kiviluoto,et al.  Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis , 1998, The Lancet.

[212]  U. Haag Technologies for Automating Randomized Treatment Assignment in Clinical Trials , 1998 .

[213]  J. Bradley How To Report Statistics In Medicine: Annotated Guidelines for Authors, Editors, and Reviewers , 1998 .

[214]  E. Franssen How to Report Statistics in Medicine , 2008, Nature Medicine.

[215]  A. Mantingh,et al.  Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term , 1997, The Lancet.

[216]  M. Tramèr,et al.  Impact of covert duplicate publication on meta-analysis: a case study , 1997, BMJ.

[217]  Lain Chalmers Assembling Comparison Groups to Assess the Effects of Health care * , 1997, Journal of the Royal Society of Medicine.

[218]  Quoting intermediate analyses can only mislead , 1997, BMJ.

[219]  Douglas G Altman,et al.  Statistics Notes: Units of analysis , 1997, BMJ.

[220]  K. Dickersin How important is publication bias? A synthesis of available data. , 1997, AIDS education and prevention : official publication of the International Society for AIDS Education.

[221]  John Hoey,et al.  Uniform Requirements for Manuscripts Submitted to Biomedical Journals , 1997, Annals of Internal Medicine.

[222]  R. Horton,et al.  Uniform Requirements for Manuscripts Submitted to Biomedical Journals , 1989 .

[223]  J Savulescu,et al.  Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability , 1996, BMJ.

[224]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[225]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[226]  D G Altman,et al.  Statistics notes: Interaction 3: How to examine heterogeneity , 1996 .

[227]  James Hartley,et al.  Obtaining information accurately and quickly: are structured abstracts more efficient? , 1996, J. Inf. Sci..

[228]  D G Altman,et al.  Statistics Notes: Interaction 2: compare effect sizes not P values , 1996, BMJ.

[229]  U Grouven,et al.  Logistic regression models used in medical research are poorly presented , 1996, BMJ.

[230]  Kenneth F Schulz,et al.  Randomised trials, human nature, and reporting guidelines , 1996, The Lancet.

[231]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[232]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[233]  P. Gøtzsche,et al.  Blinding during data analysis and writing of manuscripts. , 1996, Controlled clinical trials.

[234]  N. Talley,et al.  Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. , 1996, The American journal of gastroenterology.

[235]  J. Hall,et al.  Methodologic standards in surgical trials. , 1996, Surgery.

[236]  R. J. Hayes,et al.  Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology , 1996, BMJ.

[237]  D. Moher,et al.  Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews , 1996, The Lancet.

[238]  N. Talley,et al.  Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. , 1996, The American journal of gastroenterology.

[239]  M. Gardner,et al.  More informative abstracts revisited. , 1990, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[240]  Igor Sartori,et al.  Empirical Evidence of Bias. Dimensions of Methodological Quality Associated with Estimates of Treatment Effects in Controlled Trials , 1996 .

[241]  K. Schulz,et al.  Subverting randomization in controlled trials. , 1995, JAMA.

[242]  D G Altman,et al.  Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons , 1995, BMJ.

[243]  D. G. Altman,et al.  Review of survival analyses published in cancer journals. , 1995, British Journal of Cancer.

[244]  P. Gøtzsche,et al.  Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis , 1995, BMJ.

[245]  R. Horton The rhetoric of research , 1995, BMJ.

[246]  D. Rennie Reporting randomized controlled trials. An experiment and a call for responses from readers. , 1995, JAMA.

[247]  B L Humphreys,et al.  Structured abstracts in MEDLINE, 1989-1991. , 1995, Bulletin of the Medical Library Association.

[248]  D. Sackett,et al.  The number needed to treat: a clinically useful measure of treatment effect , 1995, BMJ.

[249]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[250]  D. Rubin,et al.  Intention‐to‐treat analysis and the goals of clinical trials , 1995, Clinical pharmacology and therapeutics.

[251]  S. Senn,et al.  Base Logic: Tests of Baseline Balance in Randomized Clinical Trials , 1995 .

[252]  Curtis L. Meinert,et al.  A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. , 1994, JAMA.

[253]  L. Wright,et al.  A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infant , 1994 .

[254]  S. Goodman,et al.  The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.

[255]  D G Altman,et al.  Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. , 1994, JAMA.

[256]  D. Moher,et al.  Statistical power, sample size, and their reporting in randomized controlled trials. , 1994, JAMA.

[257]  J. Cuzick,et al.  More on zidovudine in asymptomatic HIV infection. , 1994, The New England journal of medicine.

[258]  T R Einarson,et al.  Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[259]  B. Demichelis,et al.  Completeness of reporting trial results: effect on physicians' willingness to prescribe , 1994, The Lancet.

[260]  J. Tyson,et al.  A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 1994, The New England journal of medicine.

[261]  D G Altman,et al.  The scandal of poor medical research , 1994, BMJ.

[262]  M. Egger,et al.  Who benefits from medical interventions? , 1994, BMJ.

[263]  J. Noseworthy,et al.  The impact of blinding on the results of a randomized, placebo‐controlled multiple sclerosis clinical trial , 1994, Neurology.

[264]  Call for Comments on a Proposal To Improve Reporting of Clinical Trials in the Biomedical Literature , 1994, Annals of Internal Medicine.

[265]  D. Machin,et al.  Intention to treat--who should use ITT? , 1993, British Journal of Cancer.

[266]  J. Heiligenstein Treatment of attention-deficit/hyperactivity disorder , 1993 .

[267]  M. Buyse Interim analyses, stopping rules and data monitoring in clinical trials in Europe. , 1993, Statistics in medicine.

[268]  J. Concato,et al.  The Risk of Determining Risk with Multivariable Models , 1993, Annals of Internal Medicine.

[269]  C D Naylor,et al.  Measured Enthusiasm: Does the Method of Reporting Trial Results Alter Perceptions of Therapeutic Effectiveness? , 1992, Annals of Internal Medicine.

[270]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[271]  G H Guyatt,et al.  A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.

[272]  J H Ellenberg,et al.  Analysis of clinical trials by treatment actually received: is it really an option? , 1991, Statistics in medicine.

[273]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[274]  J J Shuster,et al.  Median follow-up in clinical trials. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[275]  D. Grimes,et al.  Preventing IUCD‐related pelvic infection: The efficacy of prophylactic doxycycline at insertion , 1991, British journal of obstetrics and gynaecology.

[276]  S Greenland,et al.  Randomization, Statistics, and Causal Inference , 1990, Epidemiology.

[277]  G. Enas,et al.  Baseline Comparability in Clinical Trials: Prevention of “Poststudy Anxiety” , 1990 .

[278]  D. G. Altman,et al.  Randomisation and baseline comparisons in clinical trials , 1990, The Lancet.

[279]  V. Torri,et al.  Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. , 1989, JAMA.

[280]  P. Gøtzsche Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.

[281]  Lois Ann Colaianni,et al.  Uniform Requirements for Manuscripts Submitted to Biomedical Journals , 1991, The Medical journal of Australia.

[282]  S. Pocock,et al.  Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.

[283]  J. Lachin Properties of simple randomization in clinical trials. , 1988, Controlled clinical trials.

[284]  D L Sackett,et al.  An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.

[285]  J C Bailar,et al.  Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. , 1988, Annals of internal medicine.

[286]  P. Gøtzsche Reference bias in reports of drug trials. , 1987, British medical journal.

[287]  S. Pocock,et al.  Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.

[288]  Dwight Lemon,et al.  Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .

[289]  T C Chalmers,et al.  Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. , 1987, Statistics in medicine.

[290]  Laurence H. Baker,et al.  Clinical Trials: Design, Conduct, and Analysis , 1987 .

[291]  N L Geller,et al.  Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. , 1987, Biometrics.

[292]  R. Simes Publication bias: the case for an international registry of clinical trials. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[293]  S. Pocock,et al.  Interim Analyses in Randomized Clinical Trials , 1986 .

[294]  M. Gardner,et al.  Confidence intervals rather than P values: estimation rather than hypothesis testing. , 1986, British medical journal.

[295]  D. Berry,et al.  Interim analyses in clinical trials: classical vs. Bayesian approaches. , 1985, Statistics in medicine.

[296]  D. Altman Comparability of Randomised Groups , 1985 .

[297]  M. Palmer Clinical Trials: A Practical Approach , 1985 .

[298]  G H Guyatt,et al.  Effect of encouragement on walking test performance. , 1984, Thorax.

[299]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.

[300]  Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. , 1982, British heart journal.

[301]  Peter Davies,et al.  Statistical guidelines for contributors to medical journals , 1983 .

[302]  M. Gardner,et al.  Statistical guidelines for contributors to medical journals. , 1983, British medical journal.

[303]  F. Mosteller,et al.  Reporting on methods in clinical trials. , 2019, The New England journal of medicine.

[304]  J. Hall,et al.  Misuse of statistical methods in the Australasian surgical literature. , 1982, The Australian and New Zealand journal of surgery.

[305]  Frederick Mosteller,et al.  Reporting on methods in clinical trials. , 1982, The New England journal of medicine.

[306]  S. Pocock Statistical Aspects of Clinical Trial Design , 1982 .

[307]  D G Altman,et al.  Statistics in medical journals. , 1982, Statistics in medicine.

[308]  P Armitage,et al.  The role of randomization in clinical trials. , 1982, Statistics in medicine.

[309]  D. DeMets,et al.  The randomized clinical trial: bias in analysis. , 1981, Circulation.

[310]  D. Sackett,et al.  Controversy in counting and attributing events in clinical trials. , 1979, The New England journal of medicine.

[311]  T C Chalmers,et al.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. , 1978, The New England journal of medicine.

[312]  J. Tukey Some thoughts on clinical trials, especially problems of multiplicity. , 1977, Science.

[313]  S M Gore,et al.  Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976. , 1977, British medical journal.

[314]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[315]  T C Chalmers,et al.  Ascorbic acid for the common cold. A prophylactic and therapeutic trial. , 1975, JAMA.

[316]  W. S. Fields,et al.  Joint Study of Extracranial Arterial Occlusion: VII. Subclavian Steal—A Review of 168 Cases , 1972 .

[317]  W. S. Fields,et al.  Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. , 1970 .

[318]  S. Schor,et al.  Statistical evaluation of medical journal manuscripts. , 1966, JAMA.

[319]  D. Campbell Factors relevant to the validity of experiments in social settings. , 1957, Psychological bulletin.

[320]  Douglas G. Altman,et al.  Explanation and Elaboration , 2022 .